Smart ring challenger Circular has officially launched the Circular Ring 3 Series at IFA 2026 in Berlin, introducing two designs that integrate advanced health monitoring with built-in contactless ...

Circular, one of the smaller stars in the smart ring galaxy, is rocking up to IFA to debut its new ring; the Series 3. The company has made its name bundling in more complex hardware than its rivals, ...

The Circular Ring 3 comes in two versions including a more discreet Slim model that skips AFib detection. The Circular Ring 3 comes in two versions including a more discreet Slim model that skips AFib ...

Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. Andy has reviewed hundreds of smartphones and tablets, ...

The Circular Ring 3 Pro and Slim add NFC payments and haptic feedback, and still don’t require subscriptions for its core health features and AI coach. The Circular Ring 3 Slim comes in four finishes.

In Florida, the Daily Digest announced the 50 Hottest Companies in the Bioeconomy for 2026, as voted by the Digest’s readers and invited selectors. For the first time, EVERY took the #1 slot in the ...

The partnership brings together UNIDO's role in industrial policy, standards and international development with CATL's experience in battery manufacturing and clean-energy technologies. Neither party ...

WASHINGTON, Aug 5 (Reuters) - Astronomers have obtained the highest-resolution images to date of our sun's visible surface, observing swirling, vortex-like patterns in superheated solar gases ...

Nvidia Corp. is working on a fresh round of AI deals worth more than $750 billion, accelerating investments that skeptics have warned are artificially inflating demand and valuations across the ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

Machine learning–based transcriptomic signatures to predict treatment outcomes across targeted and immunotherapy regimens in renal cell carcinoma. Cabozantinib plus nivolumab (C+N) versus sunitinib (S ...